UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024549
Receipt number R000028242
Scientific Title Preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer: single institutional pilot study
Date of disclosure of the study information 2016/11/01
Last modified on 2022/04/29 09:40:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer: single institutional pilot study

Acronym

Preoperative chemoradiotherapy using IMRT for locally advanced rectal cancer: pilot study

Scientific Title

Preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer: single institutional pilot study

Scientific Title:Acronym

Preoperative chemoradiotherapy using IMRT for locally advanced rectal cancer: pilot study

Region

Japan


Condition

Condition

Rectal cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of study is to evaluate whether IMRT reduces the acute toxicity in the preoperative chemoradiotherapy for rectal cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of grade 2 acute gastrointestinal toxicity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

1) Preoperative chemoradiotherapy
i) Intensity-modulated radiotherapy: 45 Gy/25frs/5weeks
ii) S-1 80-120mg/body, p.o (days 1-5, 8-12, 22-26, 29-33), CPT-11, 60 mg/m2, div (days 1, 8, 22, 29)
2) Operation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically confirmed adenocarcionma
2) Resectable rectal cancer
i) clinically T3-4 and N0-2
ii) Ra or Rb
iii) Inferior margin of tumor is located below the peritoneal reflection
3) No hepatic, peritoneal metastasis
4) 20-80 years
5) Performance Status: 0-2
6) No previous treatment
7) Adequate organ function
8) Able to take drugs orally
9) Written informed consent

Key exclusion criteria

1) Active other synchronous cancer
2) Receiving flucytosin or atazonavi
3) Suffering the active infection
4) Uncontrollable comorbidity
5) Pregnant or breastfeeding women,
6) Reciving steroid medication
7) Difficult to join due to mental disorder

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Mizowaki

Organization

Kyoto university graduate school of medicin

Division name

Department of radiation oncology and image-applied therapy

Zip code

606-8507

Address

54 Sho-goinn Kawahara cho, Sakyoku, Kyoto, Kyoto

TEL

075-751-3762

Email

mizo@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Katsuyuki
Middle name
Last name Sakanaka

Organization

Kyoto university graduate school of medicine

Division name

Department of radiation oncology and image-applied therapy

Zip code

6068507

Address

54 Sho-goinn Kawahara cho, Sakyoku, Kyoto, Kyoto

TEL

075-751-3762

Homepage URL


Email

sakanaka@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto university

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

Tel

075-753-4642

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 10 Month 24 Day

Date of IRB

2017 Year 01 Month 18 Day

Anticipated trial start date

2017 Year 01 Month 18 Day

Last follow-up date

2024 Year 01 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 24 Day

Last modified on

2022 Year 04 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028242